Peking University First Hospital: Carcinoma trials

The registry lists 12 Carcinoma studies with Peking University First Hospital as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 2 2No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)RecruitingNCT06991868
• HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort StudyNot yet recruitingNCT06798246
• Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCsRecruitingNCT06652022Not applicable
• Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUCRecruitingNCT06598761
• 68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell CarcinomaRecruitingNCT06519760Not applicable
• Neoadjuvant Radiotherapy for High-risk UTUCNot yet recruitingNCT06472752
• Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell CarcinomaRecruitingNCT06391879
• Optimization of Management for Sporadic Bilateral Renal Cell CarcinomaCompletedNCT06369519
• Observational Study of Camrelizumab Combined With Apatinib and Hyperfractionated Radiotherapy for Renal Cell CarcinomaStatus unknownNCT04609293
• Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma)Status unknownNCT03230201Not applicable
• Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma PatientsStatus unknownNCT02923557Phase 2
• Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma PatientsStatus unknownNCT02740426Phase 2